Inactive Instrument

Analyst Reco. Capricor Therapeutics Inc OTC Bulletin Board

Equities

Oppenheimer Initiates Capricor Therapeutics at Outperform Rating	17/05	MT
HC Wainwright Raises Price Target on Capricor Therapeutics to $40 From $18, Keeps Buy Rating	04/23/04	MT
Ladenburg Thalmann Starts Capricor Therapeutics at Buy With $15 Price Target	26/22/26	MT
HC Wainwright Adjusts Capricor Therapeutics' Price Target to $18 From $14, Reiterates Buy Rating	31/22/31	MT
CAPRICOR THERAPEUTICS : HC Wainwright Boosts Price Target on Capricor Therapeutics to $14 From $9, Keeps Buy Rating	11/21/11	MT

No results for this search